Eli Roth‘s recently-launched company The Horror Section has signed a deal with Construction Film, the German-based production banner founded by producer and actress Veronica Ferres (“The ...

You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Jared Kushner and Ivanka Trump attend the Manus x Machina Fashion in an Age of Technology Costume Institute Gala at the Metropolitan Museum of Art — Photo by ...

According to Pro Football Focus, it is Duke wide receiver Eli Pancol -- an unsurprising pick due to his rare physical traits and clear upside. "Travis Hunter’s arrival completely changes the ...

Eli Lilly recently announced the impressive results of its SURMOUNT-5 trial, highlighting Zepbound's efficacy over Wegovy in weight management. This promising development was disclosed alongside ...

Here’s an idea for the next episode of “The Eli Manning Show.” The former quarterback visits various investors and tries to pool enough money to buy a minority ownership stake in the Giants.

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

During a stand-up set at the end of Disney's 2025 upfront presentation on Tuesday, the comedian roasted Peyton Manning and Eli Manning for their song-and-dance routine from earlier in the afternoon.

Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price. *Stock prices used were the afternoon prices of May 15, 2025. The video was published on May 17 ...

The last couple of quarters have been very favorable for Eli Lilly and Company (NYSE:LLY) and its position in the obesity and adjacent markets. The main competitor Novo Nordisk A/S (NVO ...